Panorama Laboratories is building a new class of lab devices. Instead of measuring characteristics of samples, we measure characteristics of protocols while they are being executed. These devices will allow for instant and objective documentation of high impact actions in the lab.

Pectcof technology unlocks the potential of the coffee pulp as a source of bio based materials, at the same time detoxifying the waste stream produced by the second most traded commodity in the world.

Chronic obstructive pulmonary disease (COPD) stands as the world's third leading cause of death, lacking a cure to date. Our pioneering efforts focus on developing a small molecule targeting a novel protein involved in the restoration of ciliated cells within COPD airways.

Easy & accurate long-term monitoring for Atrial Fibrillation. By providing unobtrusive, long-term monitoring and reliable diagnosis, Praxa Sense offers a solution to detect heart rhythm diseases in an early stage, preventing up to 9 strokes each day in The Netherlands alone.

We developed a test that accurately identifies patients that will develop rheumatoid arthritis within 3 years. Our mission is to substantially reduce the high burden of this disease by helping rheumatologists worldwide identify these high-risk patients in order to start preventive therapy.

PrecorDx develops a non-invasive diagnostic platform aimed at reducing hospital admissions and mortality in heart failure (19.5M patients in the USA and EU). This new diagnostic modality is based on the unique, novel Radio-Frequency Sensing (RFS) technology.

Predica’s mission is to personalize the population based screening program cervical cancer and thereby prevent overdiagnosis and unnecessary treatment of healthy women who test positive in the current screening program.

Prolira provides the first proprietary and validated biomarker-based medical device to detect the onset of delirium, with a sensitivity of 90%. This enables health care professionals in realising better patient outcome, saving hospital days and reducing costs.

Combating viral infectious diseases with a high unmet medical need. Treating disease via protease inhibition.

Aiming to contribute to more effective drugs, QTM BioSciences’ technology provides the last mile of a drug’s journey to its target by visualizing its distribution inside a cell.